動物用藥物敏感性檢驗的全球市場，動物類別，各產品類型，各終端用戶，各地區，機會，預測，2018年～2032年

全球獸用抗生素藥敏試驗市場預計將從2024年的11.1億美元成長到2032年的17.2億美元，2025年至2032年的複合年增長率為5.61%。該市場的主要驅動因素包括主要獸醫機構監管和培訓力度的加大、人工智慧(AI)在抗生素藥敏試驗(AST)領域應用潛力的不斷增長、牲畜數量的增長以及動物抗生素抗藥性(AMR)的不斷增強。

由於動物抗生素抗藥性問題日益嚴重以及人們對抗生素正確劑量認識的不斷提高，全球獸用抗生素藥敏試驗(AST)市場正在穩步增長。 AST 流程為獸醫專業人員提供重要訊息，幫助他們為牲畜和伴侶動物選擇合適的細菌感染治療方法，從而減少抗生素濫用。此方法遵循全球 "同一健康" 原則，在動物健康、人類健康和環境健康之間建立了緊密的聯繫。由於法規更加嚴格，以及尋求 AST 服務的獸醫專業人員和寵物主人意識的不斷提高，獸醫診斷行業正在經歷成長。獸醫參考實驗室以及診所和醫院正在將 AST 檢測作為標準診斷程序，以提高治療成功率並預防抗生素抗藥性。自動化檢測設備、快速診斷方法和人工智慧評估系統的引入正在提高檢測程式的準確性和速度。在動物數量眾多的地區，市場正在蓬勃發展，同時獸醫設施也不斷發展。透過鼓勵抗生素管理的政府計畫和對獸醫保健的資金支持，市場正在不斷擴大。儘管獸用抗生素殘留檢測 (AST) 市場面臨高昂檢測成本和本地檢測限制等障礙，但得益於技術進步、監管框架和全球衛生目標的推進，該市場未來仍展現出強勁的成長潛力。

例如，2023 年 9 月，蒙古糧農組織培訓了 21 個省份的 50 多名獸醫實驗室分析員，以檢測抗生素殘留和抗菌素抗藥性。此次培訓是 ACT 和 MPTF 計畫的一部分，旨在透過實踐和理論學習來加強食品安全和公共衛生。此類項目將刺激獸藥敏感性檢測的需求。

目錄

第1章 計劃的範圍和定義

第2章 調查手法

第3章 美國的關稅的影響

第4章 摘要整理

第5章 全球動物用藥物敏感性檢驗市場展望，2018年～2032年

• 市場規模分析與預測
  • 各金額
• 市場佔有率分析與預測
  • 動物類別
    • 生產
    • 伴同性
  • 各產品
    • 配件與消耗品
    • 自動化AST設備
    • 細胞培養培養基
    • 光碟和板
  • 各終端用戶
    • 獸醫參考實驗室
    • 獸醫調查機關
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲
  • 各企業市場佔有率分析(前五名公司以及其他- 各金額，2024年)
• 2024年市場地圖分析
  • 動物類別
  • 各產品
  • 各終端用戶
  • 各地區

第6章 北美的動物用藥物敏感性檢驗市場展望，2018年～2032年

• 市場規模分析與預測
  • 各金額
• 市場佔有率分析與預測
  • 動物類別
    • 生產
    • 伴同性
  • 各產品
    • 配件與消耗品
    • 自動化AST設備
    • 細胞培養培養基
    • 光碟和板
  • 各終端用戶
    • 獸醫參考實驗室
    • 獸醫調查機關
    • 其他
  • 各國佔有率
    • 美國
    • 加拿大
    • 墨西哥
• 各國市場評估
  • 美國的動物用藥物敏感性檢驗市場展望，2018年～2032年
    • 市場規模分析與預測
    • 市場佔有率分析與預測
  • 加拿大
  • 墨西哥

所有部門市市場均涵蓋所有地區和國家。

第7章 歐洲的動物用藥物敏感性檢驗市場展望，2018年～2032年

• 德國
• 法國
• 義大利
• 英國
• 俄羅斯
• 荷蘭
• 西班牙
• 土耳其
• 波蘭

第8章 亞太地區的動物用藥物敏感性檢驗市場展望，2018年～2032年

• 印度
• 中國
• 日本
• 澳洲
• 越南
• 韓國
• 印尼
• 菲律賓

第9章 南美的動物用藥物敏感性檢驗市場展望，2018年～2032年

• 巴西
• 阿根廷

第10章 中東·非洲的動物用藥物敏感性檢驗市場展望，2018年～2032年

• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 南非

第11章 價值鏈分析

第12章 波特的五力分析

第13章 大環境分析

第14章 價格分析

第15章 市場動態

• 推動市場要素
• 市場課題

第16章 市場趨勢與發展

第17章 案例研究

第18章 競爭情形

• 前五名市場領導公司的競爭矩陣
• 前五名企業的SWOT分析
• 前10名市場主要企業的形勢
  • BioMerieux SA
  • 公司概要
  • 主要經營團隊
  • 產品和服務
  • 財務狀況(報告那樣)
  • 主要市場的著重和地理存在感
  • 最近的趨勢/合作/夥伴關係/合併和收購
  • Becton, Dickinson and Company
  • Synoptics Group
  • 泰國ermo Fisher Scientific, Inc.
  • Bruker Corporation
  • Danaher Corporation
  • Laboratorios Conda, SA
  • Bioguard Corporation
  • Liofilchem Srl
  • Bio-Rad Laboratories, Inc.

以上公司非基於市場份額排序，並且可能會根據研究過程中可用的信息而變化。

第19章 策略性建議

第20章 關於調查公司·免責聲明

Global veterinary antimicrobial susceptibility testing market is projected to witness a CAGR of 5.61% during the forecast period 2025-2032, growing from USD 1.11 billion in 2024 to USD 1.72 billion in 2032. The market is primarily driven by factors like rising regulatory and training initiatives among leading veterinary organizations, the growing potential of artificial intelligence (AI) in antimicrobial susceptibility testing (AST), the rising livestock population, and growing antimicrobial resistance (AMR) among animals.

Global veterinary antimicrobial susceptibility testing (AST) market is growing steadily because of rising animal antimicrobial resistance issues and expanding awareness about correct antibiotic practices. The process of AST provides essential information for veterinary professionals to select proper bacterial infection treatments in both livestock and companion animals, which reduces antimicrobial misuse. The method follows worldwide One Health principles by establishing strong links between animal health and human health and environmental health. The veterinary diagnostic sector experiences growth because of stricter regulations and rising awareness among veterinary professionals and pet owners who seek AST services. Veterinary reference laboratories, together with clinics and hospitals, use AST testing as a standard diagnostic procedure to improve treatment success rates and prevent antimicrobial resistance. The implementation of automated testing devices along with quick diagnostic approaches and artificial intelligence evaluation systems has enhanced the precision and speed of testing procedures. The market shows increasing strength in regions that maintain substantial animal numbers while veterinary facilities continue to develop. The market expands through government programs that encourage antimicrobial stewardship and veterinary healthcare funding. The veterinary AST market demonstrates robust future growth potential because of technological advancements alongside regulatory frameworks and worldwide health objectives, although it faces obstacles from expensive testing and rural testing restrictions.

For instance, in September 2023, FAO Mongolia trained over 50 veterinary laboratory analysts in 21 provinces to detect antibiotic residues and antimicrobial resistance. The training is identified as part of the ACT and MPTF projects, intended to strengthen food safety and public health through practical and theory-based learning. Such programs boost the demand for the veterinary antimicrobial susceptibility testing market.

Rising Prevalence of Antimicrobial Resistance Boosts Market Demand

The increasing occurrence of antimicrobial resistance (AMR) in animals represents a primary factor that escalates the need for veterinary antimicrobial susceptibility testing (AST). Excessive and incorrect use of antibiotics in livestock and companion animals has produced bacteria that resist treatment, leading to difficult medical interventions and increased disease transmission potential. The increasing resistance of pathogens endangers animal well-being and generates major public health threats because these resistant pathogens can reach humans through direct animal interactions or food consumption. Veterinary AST enables veterinarians to select the best antimicrobial drugs that specifically address certain infections, thus providing them with data to deliver precise treatments. Veterinary professionals together with farmers and pet owners and regulatory agencies, now focus more heavily on responsible antibiotic practices because of their growing awareness of AMR. Stewardship programs mandated or suggested by governments and international health organizations require veterinary providers to conduct AST before making antibiotic prescriptions. The new medical approach has led to a substantial rise in the adoption of AST services which drives overall market expansion.

For instance, in February 2024, Avails Medical secured FDA 510(k) clearance for the eQUANT system, a rapid, automated device for antibiotic susceptibility testing. eQUANT standardizes the inoculum from positive blood cultures such that it reduces routine AST turnaround times by as much as one day and facilitates earlier and more effective targeted antibiotic therapy.

Technological Advancement in Diagnostic Testing Fuels Market Growth

Technological advancements in diagnostics are certainly propelling growth in the veterinary antimicrobial susceptibility testing (AST) market. The traditional manual testing approach works effectively but requires extensive time and causes human mistakes to occur. Modern diagnostic technologies, including automated AST systems as well as microfluidic devices and rapid molecular assays, and AI-powered platforms, produce fast, precise, and dependable testing outcomes. The new technologies enable veterinary professionals and diagnostic labs to detect pathogens quickly while determining optimal antimicrobial agents, which leads to precise and prompt treatment choices. Automated processes decrease work intensity while producing consistent outcomes, and microfluidics combined with PCR-based methods transform diagnostic turnaround times from multiple days to a few hours. The advanced diagnostic systems offer the ability to detect multiple resistance genes simultaneously within a single test, which improves the overall testing efficiency. The integration of AI technology enables data interpretation, trend analysis, and surveillance reporting, which leads to more accessible and actionable diagnostics. Veterinary practices and reference labs requiring improved productivity and antimicrobial stewardship guideline compliance drive the growing demand for advanced diagnostic tools, which expands the AST market worldwide.

For instance, in June 2023, Sysmex Corporation released a ground-breaking point-of-care system for the rapid antimicrobial susceptibility testing of urine samples in only 30 minutes in Europe. This innovation tackles urinary tract infections while supporting infection control for reducing antimicrobial resistance in clinical settings.

Veterinary Reference Laboratory Holds Largest Market Share

The veterinary antimicrobial susceptibility testing (AST) market shows its largest market share in veterinary reference laboratories because they maintain advanced infrastructure and handle high testing volumes while serving as diagnostic hubs. These laboratories maintain high-throughput automated testing systems that deliver precise and rapid antimicrobial testing for all animal species. The laboratories serve veterinary clinics, hospitals, farms, and academic institutions through large diagnostic sample processing while implementing standard testing protocols. The laboratories receive complex cases for processing while participating in antimicrobial resistance surveillance programs and delivering fast turnaround times, thus making them the preferred providers of AST services. Reference labs maintain strict quality control standards and employ skilled personnel, which results in producing reliable results. In addition, partnerships with regulators and researchers put them in an advantageous position in antimicrobial stewardship. As antibiotic therapies that target diseases increase in demand, veterinary reference laboratories continue to take the lead in both services rendered and technology adoption.

North America Dominates the Veterinary Antimicrobial Susceptibility Testing Market

North America holds a dominant position in the veterinary antimicrobial susceptibility testing (AST) market because of its superior animal health facilities, together with its robust regulatory system. The area has a relatively high level of awareness of antimicrobial resistance and the significance of targeted antibiotic use among veterinarians and animal health professionals. This high level of awareness has resulted in an increased adoption of AST in veterinary and consultant veterinary clinics, hospitals, and reference laboratories. The United States leads the market through its established surveillance networks and government antimicrobial stewardship programs, and funding for diagnostic technology development. The FDA and USDA use regulatory frameworks to advance animal antibiotic stewardship by pushing veterinary professionals toward AST testing for treatment decisions. The market receives additional support from the expanding pet population, together with growing livestock operations and rising animal health expenditures.

For instance, in January 2024, the American Veterinary Medical Association (AVMA) released six documents on animal antimicrobial susceptibility testing, providing veterinary professionals with guidance on selecting antimicrobial therapy and predicting outcomes for a range of antimicrobial agents in bacterial infections.

Impact of U.S. Tariffs on Veterinary Antimicrobial Susceptibility Testing Market

The veterinary antimicrobial susceptibility testing market faces substantial effects from U.S. tariffs on diagnostic equipment and raw materials imported from manufacturing centers, including China. Tariffs lead to increased prices of crucial instruments, together with consumables such as culture media, along with testing panels and automated systems that need importing.

The increased costs may affect veterinary clinics, together with laboratories and end-users, by decreasing the usage of advanced AST technologies, especially in practices with limited budgets. Veterinary facilities with limited resources may postpone their equipment replacements or choose manual testing methods, which result in decreased diagnostic precision and longer testing periods.

Trade policy uncertainties create supply chain disruptions, which cause inventory shortages and restrict access to premium testing components. Domestic production growth may occur as a reaction to tariffs, but it does not immediately balance out the shortfall or pricing effects.

The implementation of tariffs creates financial obstacles that could hold back market growth and slow down technological adoption in the United States' veterinary antimicrobial susceptibility testing systems.

Key Players Landscape and Outlook

The competitive landscape of the veterinary antimicrobial susceptibility market is characterized by innovation along with worldwide expansion and strategic partnerships. The main players develop modern diagnostic technologies that include automated systems and rapid molecular assays to improve both speed and precision of their testing processes. R&D investments, along with partnerships between research institutions and veterinary organizations, help these companies build stronger market positions. Their growth strategies depend on entering developing markets and providing affordable and scalable solutions. The market will experience increased competition because companies strive to meet growing demand which stems from worldwide antimicrobial resistance issues and regulatory requirements.

In June 2023, bioMerieux SA earned nine clinical laboratory IMV ServiceTrak awards, a significant achievement. These awards recognized the company's excellence across five markets, including Immunoassay, ID/AST, and Blood Culture, further underscoring its commitment to high-quality diagnostics solutions and its leadership position in the clinical laboratory market.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Impact of U.S. Tariffs

4. Executive Summary

5. Global Veterinary Antimicrobial Susceptibility Testing Market Outlook, 2018-2032F

• 5.1. Market Size Analysis & Forecast
  • 5.1.1. By Value
• 5.2. Market Share Analysis & Forecast
  • 5.2.1. By Animal Type
    • 5.2.1.1. Production
    • 5.2.1.2. Companion
  • 5.2.2. By Product
    • 5.2.2.1. Accessories and Consumables
    • 5.2.2.2. Automated AST Instruments
    • 5.2.2.3. Culture Media
    • 5.2.2.4. Disks and Plates
  • 5.2.3. By End-user
    • 5.2.3.1. Veterinary Reference Lab
    • 5.2.3.2. Vet Research Institutes
    • 5.2.3.3. Others
  • 5.2.4. By Region
    • 5.2.4.1. North America
    • 5.2.4.2. Europe
    • 5.2.4.3. Asia-Pacific
    • 5.2.4.4. South America
    • 5.2.4.5. Middle East and Africa
  • 5.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
• 5.3. Market Map Analysis, 2024
  • 5.3.1. By Animal Type
  • 5.3.2. By Product
  • 5.3.3. By End-user
  • 5.3.4. By Region

6. North America Veterinary Antimicrobial Susceptibility Testing Market Outlook, 2018-2032F

• 6.1. Market Size Analysis & Forecast
  • 6.1.1. By Value
• 6.2. Market Share Analysis & Forecast
  • 6.2.1. By Animal Type
    • 6.2.1.1. Production
    • 6.2.1.2. Companion
  • 6.2.2. By Product
    • 6.2.2.1. Accessories and Consumables
    • 6.2.2.2. Automated AST Instruments
    • 6.2.2.3. Culture Media
    • 6.2.2.4. Disks and Plates
  • 6.2.3. By End-user
    • 6.2.3.1. Veterinary Reference Lab
    • 6.2.3.2. Vet Research Institutes
    • 6.2.3.3. Others
  • 6.2.4. By Country Share
    • 6.2.4.1. United States
    • 6.2.4.2. Canada
    • 6.2.4.3. Mexico
• 6.3. Country Market Assessment
  • 6.3.1. United States Veterinary Antimicrobial Susceptibility Testing Market Outlook, 2018-2032F*
    • 6.3.1.1. Market Size Analysis & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share Analysis & Forecast
      • 6.3.1.2.1. By Animal Type
        • 6.3.1.2.1.1. Production
        • 6.3.1.2.1.2. Companion
      • 6.3.1.2.2. By Product
        • 6.3.1.2.2.1. Accessories and Consumables
        • 6.3.1.2.2.2. Automated AST Instruments
        • 6.3.1.2.2.3. Culture Media
        • 6.3.1.2.2.4. Disks and Plates
      • 6.3.1.2.3. By End-user
        • 6.3.1.2.3.1. Veterinary Reference Lab
        • 6.3.1.2.3.2. Vet Research Institutes
        • 6.3.1.2.3.3. Others
  • 6.3.2. Canada
  • 6.3.3. Mexico

All segments will be provided for all regions and countries covered

7. Europe Veterinary Antimicrobial Susceptibility Testing Market Outlook, 2018-2032F

• 7.1. Germany
• 7.2. France
• 7.3. Italy
• 7.4. United Kingdom
• 7.5. Russia
• 7.6. Netherlands
• 7.7. Spain
• 7.8. Turkey
• 7.9. Poland

8. Asia-Pacific Veterinary Antimicrobial Susceptibility Testing Market Outlook, 2018-2032F

• 8.1. India
• 8.2. China
• 8.3. Japan
• 8.4. Australia
• 8.5. Vietnam
• 8.6. South Korea
• 8.7. Indonesia
• 8.8. Philippines

9. South America Veterinary Antimicrobial Susceptibility Testing Market Outlook, 2018-2032F

• 9.1. Brazil
• 9.2. Argentina

10. Middle East and Africa Veterinary Antimicrobial Susceptibility Testing Market Outlook, 2018-2032F

• 10.1. Saudi Arabia
• 10.2. UAE
• 10.3. South Africa

11. Value Chain Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

• 15.1. Market Drivers
• 15.2. Market Challenges

16. Market Trends and Developments

17. Case Studies

18. Competitive Landscape

• 18.1. Competition Matrix of Top 5 Market Leaders
• 18.2. SWOT Analysis for Top 5 Players
• 18.3. Key Players Landscape for Top 10 Market Players
  • 18.3.1. BioMerieux SA
    • 18.3.1.1. Company Details
    • 18.3.1.2. Key Management Personnel
    • 18.3.1.3. Products and Services
    • 18.3.1.4. Financials (As Reported)
    • 18.3.1.5. Key Market Focus and Geographical Presence
    • 18.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 18.3.2. Becton, Dickinson and Company
  • 18.3.3. Synoptics Group
  • 18.3.4. Thermo Fisher Scientific, Inc.
  • 18.3.5. Bruker Corporation
  • 18.3.6. Danaher Corporation
  • 18.3.7. Laboratorios Conda, S.A.
  • 18.3.8. Bioguard Corporation
  • 18.3.9. Liofilchem S.r.l.
  • 18.3.10. Bio-Rad Laboratories, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

19. Strategic Recommendations

20. About Us and Disclaimer

List of Tables

• Table 1. Competition Matrix of Top 5 Market Leaders
• Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Global Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
• Figure 2. Global Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
• Figure 3. Global Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
• Figure 4. Global Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
• Figure 5. Global Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Region, 2018-2032F
• Figure 6. North America Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
• Figure 7. North America Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
• Figure 8. North America Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
• Figure 9. North America Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
• Figure 10. North America Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Country, 2018-2032F
• Figure 11. United States Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
• Figure 12. United States Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
• Figure 13. United States Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
• Figure 14. United States Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
• Figure 15. Canada Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
• Figure 16. Canada Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
• Figure 17. Canada Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
• Figure 18. Canada Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
• Figure 19. Mexico Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
• Figure 20. Mexico Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
• Figure 21. Mexico Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
• Figure 22. Mexico Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
• Figure 23. Europe Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
• Figure 24. Europe Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
• Figure 25. Europe Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
• Figure 26. Europe Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
• Figure 27. Europe Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Country, 2018-2032F
• Figure 28. Germany Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
• Figure 29. Germany Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
• Figure 30. Germany Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
• Figure 31. Germany Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
• Figure 32. France Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
• Figure 33. France Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
• Figure 34. France Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
• Figure 35. France Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
• Figure 36. Italy Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
• Figure 37. Italy Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
• Figure 38. Italy Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
• Figure 39. Italy Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
• Figure 40. United Kingdom Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
• Figure 41. United Kingdom Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
• Figure 42. United Kingdom Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
• Figure 43. United Kingdom Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
• Figure 44. Russia Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
• Figure 45. Russia Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
• Figure 46. Russia Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
• Figure 47. Russia Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
• Figure 48. Netherlands Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
• Figure 49. Netherlands Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
• Figure 50. Netherlands Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
• Figure 51. Netherlands Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
• Figure 52. Spain Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
• Figure 53. Spain Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
• Figure 54. Spain Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
• Figure 55. Spain Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
• Figure 56. Turkey Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
• Figure 57. Turkey Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
• Figure 58. Turkey Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
• Figure 59. Turkey Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
• Figure 60. Poland Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
• Figure 61. Poland Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
• Figure 62. Poland Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
• Figure 63. Poland Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
• Figure 64. South America Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
• Figure 65. South America Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
• Figure 66. South America Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
• Figure 67. South America Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
• Figure 68. South America Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Country, 2018-2032F
• Figure 69. Brazil Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
• Figure 70. Brazil Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
• Figure 71. Brazil Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
• Figure 72. Brazil Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
• Figure 73. Argentina Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
• Figure 74. Argentina Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
• Figure 75. Argentina Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
• Figure 76. Argentina Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
• Figure 77. Asia-Pacific Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
• Figure 78. Asia-Pacific Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
• Figure 79. Asia-Pacific Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
• Figure 80. Asia-Pacific Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
• Figure 81. Asia-Pacific Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Country, 2018-2032F
• Figure 82. India Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
• Figure 83. India Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
• Figure 84. India Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
• Figure 85. India Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
• Figure 86. China Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
• Figure 87. China Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
• Figure 88. China Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
• Figure 89. China Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
• Figure 90. Japan Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
• Figure 91. Japan Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
• Figure 92. Japan Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
• Figure 93. Japan Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
• Figure 94. Australia Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
• Figure 95. Australia Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
• Figure 96. Australia Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
• Figure 97. Australia Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
• Figure 98. Vietnam Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
• Figure 99. Vietnam Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
• Figure 100. Vietnam Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
• Figure 101. Vietnam Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
• Figure 102. South Korea Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
• Figure 103. South Korea Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
• Figure 104. South Korea Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
• Figure 105. South Korea Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
• Figure 106. Indonesia Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
• Figure 107. Indonesia Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
• Figure 108. Indonesia Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
• Figure 109. Indonesia Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
• Figure 110. Philippines Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
• Figure 111. Philippines Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
• Figure 112. Philippines Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
• Figure 113. Philippines Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
• Figure 114. Middle East & Africa Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
• Figure 115. Middle East & Africa Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
• Figure 116. Middle East & Africa Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
• Figure 117. Middle East & Africa Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
• Figure 118. Middle East & Africa Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Country, 2018-2032F
• Figure 119. Saudi Arabia Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
• Figure 120. Saudi Arabia Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
• Figure 121. Saudi Arabia Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
• Figure 122. Saudi Arabia Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
• Figure 123. UAE Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
• Figure 124. UAE Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
• Figure 125. UAE Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
• Figure 126. UAE Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
• Figure 127. South Africa Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
• Figure 128. South Africa Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
• Figure 129. South Africa Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
• Figure 130. South Africa Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
• Figure 131. By Animal Type Map-Market Size (USD Billion) & Growth Rate (%), 2024
• Figure 132. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2024
• Figure 133. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
• Figure 134. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024